NCT06985108

Brief Summary

Nasotracheal intubation is often preferred in patients under general anesthesia for maxillofacial surgery or dental treatment to ensure airway safety and to work more comfortably in the surgical field. Compared to orotracheal intubation, the nasotracheal approach is a more convenient option, especially during procedures whose surgical site is in the oral region. Standard spiral intubation tubes are commonly used for nasotracheal intubation. However, there are also pre-shaped nasal intubation tubes that are specially designed to better fit the nasopharyngeal anatomical structure. The North Polar Tube, one of the most prominent of these tubes, is preferred because it is easier to insert through the nasal route and reduces potential trauma. In our hospital, nasal intubation is routinely preferred in pediatric patients under general anesthesia for dental procedures. However, there are not enough comparative studies in the literature on the advantages and disadvantages of different intubation tubes used in these applications, especially in the pediatric age group. In our hospital, nasal intubation is routinely performed in pediatric patients undergoing general anesthesia for dental treatments. In this study, the investigators will compare the spiral intubation tube and nasotracheal intubation tube used for intubation of these patients in terms of epistaxis, intubation time and difficulty of intubation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
98

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 2, 2025

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

May 6, 2025

Completed
16 days until next milestone

First Posted

Study publicly available on registry

May 22, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2025

Completed
Last Updated

February 10, 2026

Status Verified

February 1, 2026

Enrollment Period

4 months

First QC Date

May 6, 2025

Last Update Submit

February 9, 2026

Conditions

Keywords

nazotracheal intubationnorth polar tubeepistaxisspiral tube

Outcome Measures

Primary Outcomes (2)

  • epistaxis frequency

    epistaxis presence will be controlled at 0. minute and 5. minute after intubation. Epistaxis occurancy will be noted as present/absent. More incidence of epistaxis will be related to worse outcome.

    perioperative period

  • severity of epistaxis

    epistaxis severity will be measured at 0.and 5. minute after intubation. Severity will be classified as; none:no blood observed on either the surface of the tube or the posterior pharyngeal wall mild:blood apparent on the surface of the tube or posterior pharyngeal wall moderate: pooling of blood on the posterior pharyngeal wall severe: large amount of blood in the pharynx impeding nasotracheal intubation and necessitating urgent orotracheal intubation The outcome gets worse as it goes from none to severe.

    perioperative period

Secondary Outcomes (2)

  • intubation duration

    perioperative

  • intubation difficulty

    perioperative

Study Arms (2)

north polar tube

ACTIVE COMPARATOR

patients who intubated with north polar tube

Procedure: nazotracheal intubation

spiral tube

ACTIVE COMPARATOR

patients who intubated with spiral tube

Procedure: nazotracheal intubation

Interventions

intubation tube will be placed from nasal orifice through nazopharyngeal pathway to place into trachea

north polar tubespiral tube

Eligibility Criteria

Age3 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Being between 3-18 years old
  • No anomaly preventing nasal intubation
  • To be in ASA1-2 classification according to ASA criteria

You may not qualify if:

  • Lack of consent of the patient/ relatives
  • Facial anomaly that prevents nasal intubation
  • Being in the ASA3-4 group according to ASA criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dicle university Faculty of dentistry

Diyarbakır, Turkey (Türkiye)

Location

Related Links

MeSH Terms

Conditions

Epistaxis

Condition Hierarchy (Ancestors)

Nose DiseasesRespiratory Tract DiseasesOtorhinolaryngologic DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and SymptomsSigns and Symptoms, RespiratorySigns and Symptoms

Study Officials

  • Fikret Salik, specialist

    Dicle university faculty of medicine

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
medicine doctor anesthesiology specialist

Study Record Dates

First Submitted

May 6, 2025

First Posted

May 22, 2025

Study Start

May 2, 2025

Primary Completion

August 30, 2025

Study Completion

October 30, 2025

Last Updated

February 10, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

all collected IDP

Shared Documents
STUDY PROTOCOL
Time Frame
3 months after publication of results
Access Criteria
medicine doctors, dentists

Locations